Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor

Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor: Trial of Regular vs Irregualr Pulse for the Prevention of Stroke (TRIPPS 2.0)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00861354

Acronym

TRIPPS

Enrollment

150

Registered

2009-03-13

Start date

2009-03-31

Completion date

2009-09-30

Last updated

2010-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

atrial fibrillation, home blood pressure monitoring

Brief summary

This study assess the accuracy of a blood pressure monitor designed to detect atrial fibrillation. Subjects use the blood pressure monitor on a daily basis for 30 days and compare the readings to an ECG done at the same time.

Interventions

DEVICEMicrolife blood pressure monitor with AF detection (Microlife AFIB MLU3MQ1)

Monitoring heart rhythm daily for 30 days using the blood pressure monitor and the ECG recorder.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

any of the following * age 65 or older * hypertension * diabetes mellitus * congestive heart failure * previous stroke

Exclusion criteria

* permanent pacemaker * impalantable defibrillator

Design outcomes

Primary

Measure	Time frame
Sensitivity and specificity of the blood pressure monitor used for detecting atrial fibrillation compared to the electrocardiogram.	After final subject data is available.

Secondary

Measure	Time frame
Assess subjects understanding of the use of the device for atrial fibrillation.	After final subject data is available.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026